Harin Bio-Tech International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-12-2024
- Paid Up Capital ₹ 5.00 M
as on 03-12-2024
- Company Age 29 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -70.48%
(FY 2021)
- Profit -904.57%
(FY 2021)
- Ebitda -257.83%
(FY 2021)
- Net Worth -13.13%
(FY 2021)
- Total Assets -24.00%
(FY 2021)
About Harin Bio-Tech International
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sai Chandrasekhar and Kumar serve as directors at the Company.
- CIN/LLPIN
U01122KA1995PTC018513
- Company No.
018513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Harin Bio-Tech International Private Limited offer?
Harin Bio-Tech International Private Limited offers a wide range of products and services, including Coconut Oil, Organic Coconut Oil, Fresh, Dried & Preserved Vegetables, Vegetable & Herb Flakes, Edible Oil & Allied Products, Cosmetics, Hair & Beauty Products, Hair Oil, Virgin Coconut Oil.
Who are the key members and board of directors at Harin Bio-Tech International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Chandrasekhar  | Director | 11-Aug-1995 | Current |
Santhosh Kumar  | Director | 25-Jul-2023 | Current |
Financial Performance of Harin Bio-Tech International.
Harin Bio-Tech International Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 70.48% decrease. The company also saw a substantial fall in profitability, with a 904.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harin Bio-Tech International?
In 2021, Harin Bio-Tech International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Harin Bio-Tech International?
Unlock and access historical data on people associated with Harin Bio-Tech International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harin Bio-Tech International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harin Bio-Tech International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
